BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26345552)

  • 1. The characteristics of
    Najim M; Abu-Tineh M; Alshurafa A; Ibrahim MIM; Ansari S; Faraj H; Alateeg S; Akiki SJ; Yassin MA
    Hematology; 2024 Dec; 29(1):2360246. PubMed ID: 38804886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.
    Nieborowska-Skorska M; Maifrede S; Dasgupta Y; Sullivan K; Flis S; Le BV; Solecka M; Belyaeva EA; Kubovcakova L; Nawrocki M; Kirschner M; Zhao H; Prchal JT; Piwocka K; Moliterno AR; Wasik M; Koschmieder S; Green TR; Skoda RC; Skorski T
    Blood; 2017 Dec; 130(26):2848-2859. PubMed ID: 29042365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study.
    Ye X; Zheng Z; Wu Y; Zhang Z; Xu Z; Liu Y; Jiang L; Wu J
    Medicine (Baltimore); 2024 Jun; 103(24):e38556. PubMed ID: 38875377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.
    Jutzi JS; Marneth AE; Jiménez-Santos MJ; Hem J; Guerra-Moreno A; Rolles B; Bhatt S; Myers SA; Carr SA; Hong Y; Pozdnyakova O; van Galen P; Al-Shahrour F; Nam AS; Mullally A
    Leukemia; 2023 Feb; 37(2):359-369. PubMed ID: 36473980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
    Gigoux M; Holmström MO; Zappasodi R; Park JJ; Pourpe S; Bozkus CC; Mangarin LMB; Redmond D; Verma S; Schad S; George MM; Venkatesh D; Ghosh A; Hoyos D; Molvi Z; Kamaz B; Marneth AE; Duke W; Leventhal MJ; Jan M; Ho VT; Hobbs GS; Knudsen TA; Skov V; Kjær L; Larsen TS; Hansen DL; Lindsley RC; Hasselbalch H; Grauslund JH; Lisle TL; Met Ö; Wilkinson P; Greenbaum B; Sepulveda MA; Chan T; Rampal R; Andersen MH; Abdel-Wahab O; Bhardwaj N; Wolchok JD; Mullally A; Merghoub T
    Sci Transl Med; 2022 Jun; 14(649):eaba4380. PubMed ID: 35704596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia.
    Wang J; Hao J; He N; Ji C; Ma D
    Turk J Haematol; 2016 Sep; 33(3):180-6. PubMed ID: 26377485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow pathology of myeloproliferative neoplasms].
    Ito M
    Rinsho Ketsueki; 2015 Aug; 56(8):956-62. PubMed ID: 26345553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of genetic data to clinical practice of MPN].
    Edahiro Y
    Rinsho Ketsueki; 2015 Aug; 56(8):949-55. PubMed ID: 26345552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.
    Ojeda MJ; Bragós IM; Calvo KL; Williams GM; Carbonell MM; Pratti AF
    Hematology; 2018 May; 23(4):208-211. PubMed ID: 28990497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin exon 9 mutations in myeloproliferative neoplasms.
    Ha JS; Kim YK
    Ann Lab Med; 2015 Jan; 35(1):22-7. PubMed ID: 25553276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.
    Lin Y; Liu E; Sun Q; Ma J; Li Q; Cao Z; Wang J; Jia Y; Zhang H; Song Z; Ai X; Shi L; Feng X; Li C; Wang J; Ru K
    Am J Clin Pathol; 2015 Jul; 144(1):165-71. PubMed ID: 26071474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between Calreticulin Gene Mutation and JAK2/MPL Negative Myeloproliferative Neoplasms].
    Dong L; Shen XL; Wei W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1532-4. PubMed ID: 26524072
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.